<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="19553">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02852343</url>
  </required_header>
  <id_info>
    <org_study_id>35RC14_9878</org_study_id>
    <nct_id>NCT02852343</nct_id>
  </id_info>
  <brief_title>One-step Nucleic Acid Amplification for Detecting Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma</brief_title>
  <acronym>OSNA-ORL</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <brief_summary>
    <textblock>
      The investigators main objective is to show that OSNA technique is as accurate as
      pathological analysis (frozen section / HE staining and immunochemistry) to detect occult
      lymph node metastasis (micro and macrometastasis).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>number of CK19 mRNA copies/ÂµL of diluted lymph node lysate</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>cN0 Oral Squamous Cell Carcinomas</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with sceduled procedure to cN0 oral squamous cell carcinomas
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient &gt; 18 years old

          -  Head and neck squamous cell carcinoma diagnosed by biopsy

          -  N0 classification (N0: no lymph node invasion on clinical and radiological
             examination).

          -  Neck dissection or sentinel lymph node biopsy required to treat the patient

          -  ECOG 1,2 or 3

          -  Patient's consent

        Exclusion Criteria:

          -  Patient previously treated by radiotherapy or surgery for head and neck neoplasm.

          -  Contraindication or patient unwillingness to undergo surgical treatment

          -  Incapacitated adults
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Frank FJ JEGOU, PH-PD</last_name>
    <phone>2 99 28 52 07</phone>
    <phone_ext>33</phone_ext>
    <email>frank.jegou@chu-rennes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kristell KC COAT</last_name>
    <phone>2 99 28 25 55</phone>
    <phone_ext>33</phone_ext>
    <email>kristell.coat@chu-rennes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre hospitalier universitaire de Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank FJ JEGOU, PH-PD</last_name>
      <phone>2 99 28 52 07</phone>
      <phone_ext>33</phone_ext>
      <email>franck.jegou@chu-rennes.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>July 28, 2016</lastchanged_date>
  <firstreceived_date>July 19, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Squamous Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
